Chemotherapy and Targeted Therapy Strategies in Patients with Unresectable or Borderline Resectable Metastatic Colorectal Cancer: Evidence for a Lack of Focus on Resection Rates

BACKGROUND AND AIMS: Chemotherapy (CTx) with targeted therapy (TT) have increased the overall response rate (ORR) and improved survival in unresectable or borderline resectable metastatic colorectal cancer (mCRC). However, the resection rate is an endpoint with often suboptimal expert involvement. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zmuc, Jan, Heil, Jan, Herfarth, Caroline, Bechstein, Wolf O., Koch, Christine, Trojan, Jörg, Schnitzbauer, Andreas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Colorectal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562287/
https://www.ncbi.nlm.nih.gov/pubmed/37644249
http://dx.doi.org/10.1245/s10434-023-14049-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562287/
https://www.ncbi.nlm.nih.gov/pubmed/37644249
http://dx.doi.org/10.1245/s10434-023-14049-3

Ejemplares similares